Understand the source comparison
Peptide Clinics New York Providers Services 2026: Comparison
Telehealth GLP-1 Platform Semaglutide, tirzepatide, mazdutide Licensed MD/DO via virtual consult 503B compounding pharmacy, ships nationally $250–$450/month for medication + $150 initial consult Best for metabolic therapy access. Limited breadth for cognitive
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Telehealth GLP-1 Platform
- Semaglutide, tirzepatide, mazdutide
- Licensed MD/DO via virtual consult
- 503B compounding pharmacy, ships nationally
- $250–$450/month for medication + $150 initial consult
- Best for metabolic therapy access. Limited breadth for cognitive or immune peptides
- Integrated Longevity Clinic
- GLP-1 agonists, nootropics (cerebrolysin, dihexa), immune peptides (thymalin, KPV)
- In-house MD with telemedicine option
- Dual partnerships: 503B for GLP-1, 503A in-state for research peptides
- $400–$800/month depending on protocol complexity
- Broadest therapeutic scope but higher cost. Requires lab monitoring
- Research-Focused Peptide Supplier
- Cognitive peptides, growth hormone secretagogues (MK-677, hexarelin), experimental compounds (P21, SLU-PP-332)
- No prescribing. Research-grade only
- Direct from manufacturer. Not compounded
- $80–$300 per vial, research use only
- Highest purity for laboratory applications. Not appropriate for clinical self-administration
- Traditional Compounding Pharmacy with Peptide Services
- Custom peptide formulations per physician order
- Requires external prescriber (patient's own doctor)
- In-house 503A compounding
- Variable. Typically $200–$500 per compound depending on peptide and dose
- Good for patients with established physician relationships. Limited telehealth integration
- The cost differential reflects regulatory burden and overhead. Telehealth platforms absorb prescriber consultation fees, platform maintenance, and legal compliance costs, which is why their monthly pricing includes both medication and service. Research suppliers like Real Peptides operate under different regulations. They sell peptides for in-vitro research and laboratory use, not human administration, which exempts them from prescriber requirements but also means their products cannot be marketed for clinical use. Researchers purchasing Tesofensine or CJC-1295/Ipamorelin blends from research suppliers are responsible for ensuring compliance with institutional review board (IRB) protocols and informed consent processes.